2010 Chronic Pain Epilepsy 
Cannabis Law Report
MAY 9, 2022
The company is following in the footsteps of GW Pharmaceuticals, a trailblazer that developed the first cannabis-based medicine to be licensed in the UK in 2010, Sativex for multiple sclerosis, which costs about £2,000 a year. However, NHS prescribing of the mouth spray remains very limited and varies across the country.
Cannabis Law Report
JANUARY 3, 2022
Panaxia Israel is a subsidiary of the Panaxia Pharmaceutical Industries, founded in 2010 by Dr. Dadi Segal (PhD), Dr. Eran Goldberg (PhD) and Adv. Assi Rotbart (LL. The Panaxia Group has over 150 employees. To learn more about Panaxia, please visit: [link]. SOURCE Panaxia Pharmaceutical Industries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 28, 2019
A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain. Good news for epilepsy patients because UK authorities have finally given their nod for Epidiolex.
Cannabis Law Report
JUNE 26, 2019
I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. Dr. Weiner is certified in Interventional Pain Management and Physical Medicine and Rehabilitation. Heather also acts as a Junior Pain Ambassador with the U.S. Zachary Kobrin.
Miss Marijuana
MARCH 15, 2021
After realizing the worth of high-CBD strains to the medical community in 2010, Lawrence began to focus specially on producing high-CBD strains of cannabis and created a library of CBD genetics that everyone in the industry knowingly or unknowingly pick from. Chronic stress. Chronic Pain. Depression. Muscle Spasms.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain. Neuropathic pain. Conclusions. Palliative care indications. 2019 ; Sarris et al.
Otherside Farms
MAY 5, 2021
Many people quickly started discovering them in 2010. Over 20% of patients who use vaporizers that suffer from chronic pain, multiple sclerosis, epilepsy, and HIV find life more enjoyable with the use of cannabis strictly for therapeutic purposes. 40% of patients’ pain is reduced when they use marijuana.
Expert insights. Personalized for you.
52 
Let's personalize your content